ISL
TMO icon

Ingalls & Snyder LLC’s Thermo Fisher Scientific TMO Stock Holding History

Ingalls & Snyder LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Hold
1,093
– – 0.02% 286
2026
Q1 		$537K Sell
1,093
-1,886
-63% -$1.02M 0.02% 284
2025
Q4 		$1.73M Buy
2,979
+28
+0.9% +$15.8K 0.06% 173
2025
Q3 		$1.43M Buy
2,951
+474
+19% +$221K 0.05% 190
2025
Q2 		$1M Buy
2,477
+663
+37% +$277K 0.04% 225
2025
Q1 		$903K Buy
1,814
+426
+31% +$231K 0.03% 231
2024
Q4 		$722K Buy
1,388
+41
+3% +$22.5K 0.03% 248
2024
Q3 		$833K Buy
1,347
+147
+12% +$87K 0.03% 244
2024
Q2 		$664K Buy
1,200
+32
+3% +$18.3K 0.03% 258
2024
Q1 		$679K Sell
1,168
-4
-0.3% -$2.25K 0.03% 259
2023
Q4 		$622K Sell
1,172
-260
-18% -$126K 0.03% 261
2023
Q3 		$725K Sell
1,432
-8
-0.6% -$4.26K 0.03% 238
2023
Q2 		$751K Buy
1,440
+29
+2% +$15.6K 0.04% 244
2023
Q1 		$813K Buy
1,411
+6
+0.4% +$3.38K 0.04% 222
2022
Q4 		$774K Sell
1,405
-18
-1% -$9.54K 0.04% 226
2022
Q3 		$722K Buy
1,423
+18
+1% +$10.1K 0.04% 225
2022
Q2 		$763K Sell
1,405
-21
-1% -$11.6K 0.04% 230
2022
Q1 		$842K Sell
1,426
-7
-0.5% -$4.02K 0.04% 245
2021
Q4 		$956K Sell
1,433
-26
-2% -$16.2K 0.04% 235
2021
Q3 		$834K Buy
1,459
+120
+9% +$65.9K 0.04% 253
2021
Q2 		$675K Buy
1,339
+3
+0.2% +$1.42K 0.03% 281
2021
Q1 		$610K Sell
1,336
-45
-3% -$21.5K 0.03% 271
2020
Q4 		$643K Sell
1,381
-216
-14% -$101K 0.03% 261
2020
Q3 		$705K Buy
1,597
+152
+11% +$62.8K 0.05% 212
2020
Q2 		$524K Buy
1,445
+4
+0.3% +$1.34K 0.03% 252
2020
Q1 		$409K Sell
1,441
-221
-13% -$69.7K 0.03% 278
2019
Q4 		$540K Hold
1,662
– – 0.03% 258
2019
Q3 		$484K Buy
1,662
+115
+7% +$32.9K 0.02% 290
2019
Q2 		$454K Sell
1,547
-245
-14% -$67.5K 0.02% 303
2019
Q1 		$491K Sell
1,792
-33
-2% -$8.21K 0.02% 289
2018
Q4 		$408K Buy
1,825
+33
+2% +$7.74K 0.02% 295
2018
Q3 		$437K Sell
1,792
-300
-14% -$69K 0.02% 317
2018
Q2 		$433K Hold
2,092
– – 0.02% 288
2018
Q1 		$432K Hold
2,092
– – 0.02% 282
2017
Q4 		$397K Buy
+2,092
New +$401K 0.02% 288
2017
Q3 		– Sell
-2,025
Closed -$353K – 378
2017
Q2 		$353K Buy
2,025
+500
+33% +$84K 0.02% 275
2017
Q1 		$234K Sell
1,525
-265
-15% -$40.5K 0.01% 351
2016
Q4 		$253K Hold
1,790
– – 0.01% 343
2016
Q3 		$285K Hold
1,790
– – 0.02% 318
2016
Q2 		$264K Buy
1,790
+25
+1% +$3.69K 0.02% 343
2016
Q1 		$249K Hold
1,765
– – 0.02% 303
2015
Q4 		$250K Hold
1,765
– – 0.02% 315
2015
Q3 		$215K Buy
+1,765
New +$230K 0.01% 322
2015
Q2 		– Sell
-1,500
Closed -$201K – 388
2015
Q1 		$201K Buy
+1,500
New +$193K 0.01% 348
2014
Q1 		– Sell
-2,000
Closed -$222K – 377
2013
Q4 		$222K Buy
+2,000
New +$199K 0.01% 313

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ingalls & Snyder LLC's TMO Position: Q2 2026 in Review

Ingalls & Snyder LLC held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,093 shares worth $548K. The position accounts for 0.02% of the portfolio, ranked #286.

Ingalls & Snyder LLC first reported a position in TMO in Q4 2013 and has held it in 45 quarters since. The position peaked at $1.73M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ingalls & Snyder LLC held 1,093 shares of Thermo Fisher Scientific worth $548K as of Q2 2026.
  • Ingalls & Snyder LLC left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #286 holding.
  • Ingalls & Snyder LLC first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 45 quarters since.
  • Ingalls & Snyder LLC's Thermo Fisher Scientific position peaked at $1.73M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.